Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
Renal impairment is a typical side effect of tacrolimus (Tac) treatment in liver transplant (LT) recipients. One strategy to avoid renal dysfunction is to increase the concentration/dose (C/D) ratio by improving drug bioavailability. LT recipients converted from standard-release Tac to MeltDose<s...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/6/1654 |
id |
doaj-11b0e5437c414845a6aa255ff97d6fd7 |
---|---|
record_format |
Article |
spelling |
doaj-11b0e5437c414845a6aa255ff97d6fd72020-11-25T03:24:01ZengMDPI AGJournal of Clinical Medicine2077-03832020-06-0191654165410.3390/jcm9061654Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver TransplantationJohannes von Einsiedel0Gerold Thölking1Christian Wilms2Elena Vorona3Arne Bokemeyer4Hartmut H. Schmidt5Iyad Kabar6Anna Hüsing-Kabar7Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyDepartment of Internal Medicine and Nephrology, University Hospital of Münster Marienhospital Steinfurt, 48565 Steinfurt, GermanyDepartment of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyDepartment of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyDepartment of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyDepartment of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyDepartment of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyDepartment of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, 48149 Münster, GermanyRenal impairment is a typical side effect of tacrolimus (Tac) treatment in liver transplant (LT) recipients. One strategy to avoid renal dysfunction is to increase the concentration/dose (C/D) ratio by improving drug bioavailability. LT recipients converted from standard-release Tac to MeltDose<sup>®</sup> Tac (LCPT), a novel technological formulation, were able to reduce the required Tac dose due to higher bioavailability. Hence, we hypothesize that such a conversion increases the C/D ratio, resulting in a preservation of renal function. In the intervention group, patients were switched from standard-release Tac to LCPT. Clinical data were collected for 12 months after conversion. Patients maintained on standard-release Tac were enrolled as a control group. Twelve months after conversion to LCPT, median C/D ratio had increased significantly by 50% (<i>p</i> < 0.001), with the first significant increase seen 3 months after conversion (<i>p</i> = 0.008). In contrast, C/D ratio in the control group was unchanged after 12 months (1.75 vs. 1.76; <i>p</i> = 0.847). Estimated glomerular filtration rate (eGFR) had already significantly deteriorated in the control group at 9 months (65.6 vs. 70.6 mL/min/1.73 m<sup>2</sup> at study onset; <i>p</i> = 0.006). Notably, patients converted to LCPT already had significant recovery of mean eGFR 6 months after conversion (67.5 vs. 65.3 mL/min/1.73 m<sup>2</sup> at study onset; <i>p</i> = 0.029). In summary, conversion of LT recipients to LCPT increased C/D ratio associated with renal function improvement.https://www.mdpi.com/2077-0383/9/6/1654MeltDose<sup>®</sup>LCPTtacrolimusrenal functionliver transplantationC/D ratio |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Johannes von Einsiedel Gerold Thölking Christian Wilms Elena Vorona Arne Bokemeyer Hartmut H. Schmidt Iyad Kabar Anna Hüsing-Kabar |
spellingShingle |
Johannes von Einsiedel Gerold Thölking Christian Wilms Elena Vorona Arne Bokemeyer Hartmut H. Schmidt Iyad Kabar Anna Hüsing-Kabar Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation Journal of Clinical Medicine MeltDose<sup>®</sup> LCPT tacrolimus renal function liver transplantation C/D ratio |
author_facet |
Johannes von Einsiedel Gerold Thölking Christian Wilms Elena Vorona Arne Bokemeyer Hartmut H. Schmidt Iyad Kabar Anna Hüsing-Kabar |
author_sort |
Johannes von Einsiedel |
title |
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation |
title_short |
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation |
title_full |
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation |
title_fullStr |
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation |
title_full_unstemmed |
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation |
title_sort |
conversion from standard-release tacrolimus to meltdose<sup>®</sup> tacrolimus (lcpt) improves renal function after liver transplantation |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2020-06-01 |
description |
Renal impairment is a typical side effect of tacrolimus (Tac) treatment in liver transplant (LT) recipients. One strategy to avoid renal dysfunction is to increase the concentration/dose (C/D) ratio by improving drug bioavailability. LT recipients converted from standard-release Tac to MeltDose<sup>®</sup> Tac (LCPT), a novel technological formulation, were able to reduce the required Tac dose due to higher bioavailability. Hence, we hypothesize that such a conversion increases the C/D ratio, resulting in a preservation of renal function. In the intervention group, patients were switched from standard-release Tac to LCPT. Clinical data were collected for 12 months after conversion. Patients maintained on standard-release Tac were enrolled as a control group. Twelve months after conversion to LCPT, median C/D ratio had increased significantly by 50% (<i>p</i> < 0.001), with the first significant increase seen 3 months after conversion (<i>p</i> = 0.008). In contrast, C/D ratio in the control group was unchanged after 12 months (1.75 vs. 1.76; <i>p</i> = 0.847). Estimated glomerular filtration rate (eGFR) had already significantly deteriorated in the control group at 9 months (65.6 vs. 70.6 mL/min/1.73 m<sup>2</sup> at study onset; <i>p</i> = 0.006). Notably, patients converted to LCPT already had significant recovery of mean eGFR 6 months after conversion (67.5 vs. 65.3 mL/min/1.73 m<sup>2</sup> at study onset; <i>p</i> = 0.029). In summary, conversion of LT recipients to LCPT increased C/D ratio associated with renal function improvement. |
topic |
MeltDose<sup>®</sup> LCPT tacrolimus renal function liver transplantation C/D ratio |
url |
https://www.mdpi.com/2077-0383/9/6/1654 |
work_keys_str_mv |
AT johannesvoneinsiedel conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT geroldtholking conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT christianwilms conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT elenavorona conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT arnebokemeyer conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT hartmuthschmidt conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT iyadkabar conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation AT annahusingkabar conversionfromstandardreleasetacrolimustomeltdosesupsuptacrolimuslcptimprovesrenalfunctionafterlivertransplantation |
_version_ |
1724604039093551104 |